[go: up one dir, main page]

AU8456198A - Taxol emulsion - Google Patents

Taxol emulsion

Info

Publication number
AU8456198A
AU8456198A AU84561/98A AU8456198A AU8456198A AU 8456198 A AU8456198 A AU 8456198A AU 84561/98 A AU84561/98 A AU 84561/98A AU 8456198 A AU8456198 A AU 8456198A AU 8456198 A AU8456198 A AU 8456198A
Authority
AU
Australia
Prior art keywords
taxol
emulsion
taxol emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU84561/98A
Inventor
Stanley Stewart Davis
Jihong Han
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Danbiosyst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd
Publication of AU8456198A publication Critical patent/AU8456198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU84561/98A 1997-07-26 1998-07-24 Taxol emulsion Abandoned AU8456198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9715759.8A GB9715759D0 (en) 1997-07-26 1997-07-26 New emulsion formulations
GB9715759 1997-07-26
PCT/GB1998/002220 WO1999004787A1 (en) 1997-07-26 1998-07-24 Taxol emulsion

Publications (1)

Publication Number Publication Date
AU8456198A true AU8456198A (en) 1999-02-16

Family

ID=10816477

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84561/98A Abandoned AU8456198A (en) 1997-07-26 1998-07-24 Taxol emulsion

Country Status (5)

Country Link
EP (1) EP0999833A1 (en)
AU (1) AU8456198A (en)
GB (1) GB9715759D0 (en)
WO (1) WO1999004787A1 (en)
ZA (1) ZA986645B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727280B2 (en) 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
DE19843968A1 (en) * 1998-09-24 2000-04-13 Hans Dietl Taxane-containing pharmaceutical preparation for intravenous administration and process for their preparation
AU4053700A (en) * 1999-04-02 2000-10-23 Washington State University Research Foundation Enhanced tissue and subcellular delivery of vitamin e compounds
JP2003500368A (en) * 1999-05-24 2003-01-07 ソーナス ファーマシューティカルス，インコーポレイテッド Emulsion vehicle for poorly soluble drugs
KR20020059415A (en) * 1999-09-27 2002-07-12 스티븐 씨. 큐웨이 Compositions of tocol-soluble therapeutics
WO2002026208A2 (en) * 2000-09-27 2002-04-04 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6919370B2 (en) * 2000-11-28 2005-07-19 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
US6858227B1 (en) 2001-11-21 2005-02-22 Sonus Pharmaceuticals, Inc. Vitamin E conjugates
IL163808A0 (en) * 2002-03-01 2005-12-18 Yissum Res Dev Co Self emulsifying drug delivery systems for poorly soluble drugs
EP1340497A1 (en) * 2002-03-01 2003-09-03 Novagali Sas Self emulsifying drug delivery systems for poorly soluble drugs
DE602004027936D1 (en) 2003-10-29 2010-08-12 Sonus Pharmaceutical Inc TOCOPHEROL-MODIFIED THERAPEUTIC DRUG COMPOUND
RU2340616C2 (en) * 2003-10-29 2008-12-10 Сонус Фармасьютикалз, Инк. Tocopherol-modified therapeutical drug compounds
WO2005105041A2 (en) * 2004-04-27 2005-11-10 Formatech, Inc. Methods of enhancing solubility in water of hydrophobic compounds by micellar dispersions
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
TWI376239B (en) 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
EP2317978A2 (en) 2008-07-23 2011-05-11 Bharat Serums And Vaccines Ltd. Stable injectable oil-in-water docetaxel nanoemulsion
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US8591942B2 (en) 2009-09-23 2013-11-26 Indu JAVERI Methods for the preparation of liposomes comprising docetaxel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649155A (en) * 1983-07-22 1987-03-10 Hoffmann-La Roche Inc. Injectable solutions
CA2033725C (en) * 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
JPH06157294A (en) * 1992-11-19 1994-06-03 Tanabe Seiyaku Co Ltd Fine-granular fat preparation
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs

Also Published As

Publication number Publication date
WO1999004787A1 (en) 1999-02-04
ZA986645B (en) 2000-01-24
EP0999833A1 (en) 2000-05-17
GB9715759D0 (en) 1997-10-01

Similar Documents

Publication Publication Date Title
AU1709299A (en) Mixer-injectors
AU8921698A (en) Follistatin-3
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU5875098A (en) Processor
AU1027499A (en) 32P-polyphosphazene
AU8456198A (en) Taxol emulsion
AU9281698A (en) O/w emulsion compositions
AU6119298A (en) Emulsion composition
AU1760399A (en) New phthalazinones
AU5272198A (en) EMP-charge-eliminator
AU4117497A (en) Micropolarimeter
AU6185898A (en) Clavaspirins
AU8214598A (en) 3-benzylpiperidine
AUPP108197A0 (en) Stable emulsions
AU7761998A (en) Korrosionsschutzanstrichstoff
AU7163198A (en) Retinoid-like compounds
AU3344299A (en) Th2-migration promoters containing w/o emulsions
AU4469997A (en) Heregulin-gamma
AU5540298A (en) Rockbolts
AU7208798A (en) 1-cyano-2-alkylthio-2-arylthioethenes
AU6507298A (en) Renovative pipeliner
AU6060598A (en) Multi-hopper
AU8121298A (en) G-seat
AU7780498A (en) Cafetiere
AUPP366098A0 (en) Emulsion explosive

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase